Genomadix Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 38

Employees

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 12

Genomadix General Information

Description

Developer of a molecular test technology designed to facilitate biological testing in the areas of infectious diseases, precision medicine, and water safety. The company has developed a diagnostic platform as well as a portable molecular analyzer that uses polymerase chain reaction (PCR) technology to generate quick, accurate test results outside of a healthcare facility, enabling doctors and patients to get access to rapid diagnostics required for real-time healthcare decisions.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 340 Legget Drive
  • Suite 180
  • Kanata, Ontario K2K 2A4
  • Canada
+1 (888)
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Other Healthcare Technology Systems
Vertical(s)
Corporate Office
  • 340 Legget Drive
  • Suite 180
  • Kanata, Ontario K2K 2A4
  • Canada
+1 (888)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Genomadix Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC 01-Jan-2024 Completed Generating Revenue
3. Early Stage VC 29-Aug-2022 Completed Generating Revenue
2. Accelerator/Incubator 25-Aug-2022 $5.78M Completed Generating Revenue
1. Seed Round 19-Jul-2022 $5.78M $5.78M Completed Generating Revenue
To view Genomadix’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Genomadix Patents

Genomadix Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210054439-A1 Linearly-amplified internal control for nucleic acid amplification reaction Inactive 16-Mar-2018
US-20220282302-A1 Linearly-amplified internal control for nucleic acid amplification reaction Inactive 16-Mar-2018
US-12060548-B2 Fluid handling apparatus Active 19-Jan-2018
US-20200339928-A1 Fluid handling apparatus Active 19-Jan-2018
US-D871607-S1 Concentration detector for laboratory use Active 24-Oct-2017
To view Genomadix’s complete patent history, request access »

Genomadix Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Genomadix Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds
Angel (individual) Minority
Cliffbrake Family Office Minority
Angel (individual) Minority
Angel (individual) Minority
Maple Leaf Angels Angel Group Minority
You’re viewing 5 of 12 investors. Get the full list »

Genomadix FAQs

  • When was Genomadix founded?

    Genomadix was founded in 2021.

  • Where is Genomadix headquartered?

    Genomadix is headquartered in Kanata, Canada.

  • What is the size of Genomadix?

    Genomadix has 38 total employees.

  • What industry is Genomadix in?

    Genomadix’s primary industry is Diagnostic Equipment.

  • Is Genomadix a private or public company?

    Genomadix is a Private company.

  • What is Genomadix’s current revenue?

    The current revenue for Genomadix is .

  • How much funding has Genomadix raised over time?

    Genomadix has raised $5.78M.

  • Who are Genomadix’s investors?

    , Cliffbrake, , , and Maple Leaf Angels are 5 of 12 investors who have invested in Genomadix.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process